Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market
Holding XLO?
Track your performance easily

Xilio Therapeutics (XLO) Cash flow

100 Followers

Xilio Therapeutics Cash Flow

XLO's free cash flow for Q1 2024 was $-10.50M. For the 2024 fiscal year, XLO's free cash flow was decreased by $8.48M and operating cash flow was $-10.50M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -53.87M$ -68.62M$ -75.72M$ -80.75M$ -36.09M$ -17.84M
Investing Cash Flow
$ -316.00K$ -486.00K$ -1.87M$ -1.10M$ -2.19M$ -715.00K
Financing Cash Flow
$ -3.91M$ -6.55M$ -69.00K$ 260.67M$ 10.03M$ 60.02M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 221.34M$ 46.29M$ 121.95M$ 199.61M$ 20.79M$ 49.04M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 426.00K$ 573.00K$ 555.00K$ 492.00K$ 536.00K$ 14.00K
Issuance Of Capital Stock
$ 4.50M$ 194.00K-$ 116.36M$ 9.97M$ 50.07M
Issuance Of Debt
$ -8.42M$ -6.75M$ -85.00K$ -110.00K$ 0.00$ 9.95M
Repayment Of Debt
$ -8.42M$ -6.75M$ -85.00K$ -1.08M$ -99.00K$ 0.00
Free Cash Flow
$ -54.19M$ -69.11M$ -77.59M$ -81.85M$ -38.28M$ -18.56M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Xilio Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis